223 related articles for article (PubMed ID: 15481315)
1. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease.
Koutroubakis IE; Malliaraki N; Dimoulios PD; Karmiris K; Castanas E; Kouroumalis EA
Dig Dis Sci; 2004 Sep; 49(9):1433-7. PubMed ID: 15481315
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
[TBL] [Abstract][Full Text] [Related]
3. Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment.
Neubauer K; Kempinski R; Matusiewicz M; Bednarz-Misa I; Krzystek-Korpacka M
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30986917
[No Abstract] [Full Text] [Related]
4. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
Ciećko-Michalska I; Fedak D; Mach T
Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
[TBL] [Abstract][Full Text] [Related]
5. Decreased serum fetuin-A levels and active inflammatory bowel disease.
Ma P; Feng YC
Am J Med Sci; 2014 Jul; 348(1):47-51. PubMed ID: 24487480
[TBL] [Abstract][Full Text] [Related]
6. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.
Kapsoritakis AN; Kapsoritaki AI; Davidi IP; Lotis VD; Manolakis AC; Mylonis PI; Theodoridou AT; Germenis AE; Potamianos SP
BMC Gastroenterol; 2008 Nov; 8():55. PubMed ID: 19036126
[TBL] [Abstract][Full Text] [Related]
7. CD8
Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
[TBL] [Abstract][Full Text] [Related]
8. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease.
Solem CA; Loftus EV; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ
Inflamm Bowel Dis; 2005 Aug; 11(8):707-12. PubMed ID: 16043984
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic autoantibodies in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Drygiannakis D; Karmiris K; Drygiannakis I; Makreas S; Kouroumalis EA
Dig Dis Sci; 2005 Dec; 50(12):2330-4. PubMed ID: 16416183
[TBL] [Abstract][Full Text] [Related]
10. Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity.
Boga S; Alkim H; Koksal AR; Ozagari AA; Bayram M; Tekin Neijmann S; Sen I; Alkim C
J Investig Med; 2016 Jun; 64(5):1016-24. PubMed ID: 27001944
[TBL] [Abstract][Full Text] [Related]
11. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
12. Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease.
D'Odorico A; Bortolan S; Cardin R; D'Inca' R; Martines D; Ferronato A; Sturniolo GC
Scand J Gastroenterol; 2001 Dec; 36(12):1289-94. PubMed ID: 11761019
[TBL] [Abstract][Full Text] [Related]
13. Patients with primary biliary cirrhosis have increased serum total antioxidant capacity measured with the crocin bleaching assay.
Notas G; Miliaraki N; Kampa M; Dimoulios F; Matrella E; Hatzidakis A; Castanas E; Kouroumalis E
World J Gastroenterol; 2005 Jul; 11(27):4194-8. PubMed ID: 16015688
[TBL] [Abstract][Full Text] [Related]
14. Enhanced formation of advanced oxidation protein products in IBD.
Krzystek-Korpacka M; Neubauer K; Berdowska I; Boehm D; Zielinski B; Petryszyn P; Terlecki G; Paradowski L; Gamian A
Inflamm Bowel Dis; 2008 Jun; 14(6):794-802. PubMed ID: 18213700
[TBL] [Abstract][Full Text] [Related]
15. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
16. Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study.
Zissimopoulos A; Vradelis S; Konialis M; Chadolias D; Bampali A; Constantinidis T; Efremidou E; Kouklakis G
Scand J Gastroenterol; 2014 Aug; 49(8):942-9. PubMed ID: 24897131
[TBL] [Abstract][Full Text] [Related]
17. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases?
Kaplan M; Yuksel M; Ates I; Kilic ZM; Kilic H; Kuzu UB; Kayacetin E
J Gastroenterol Hepatol; 2016 Jun; 31(6):1120-5. PubMed ID: 26642816
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum neutrophil gelatinase-associated lipocalin (NGAL), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) levels, and their relations with disease type and activity in inflammatory bowel diseases.
Korkmaz H; Asıl M; Temel T; Öztürk B; Kebapçılar L
Turk J Med Sci; 2021 Oct; 51(5):2403-2412. PubMed ID: 33984894
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
[TBL] [Abstract][Full Text] [Related]
20. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]